These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20013551)

  • 21. The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor.
    Blum WF; Machinis K; Shavrikova EP; Keller A; Stobbe H; Pfaeffle RW; Amselem S
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4171-4. PubMed ID: 16868057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
    Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone/IGF-I axis and growth hormone receptor mutations in idiopathic short stature.
    El Kholy M; Mella P; Rashad M; Buzi F; Meazza C; Zahra S; Elsedfy HH
    Horm Res Paediatr; 2011; 76(5):300-6. PubMed ID: 21846964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease.
    Kucukhuseyin O; Toptas B; Timirci-Kahraman O; Isbir S; Karsidag K; Isbir T
    In Vivo; 2015; 29(3):371-8. PubMed ID: 25977383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the growth hormone receptor gene polymorphisms with mandibular height in a Korean population.
    Kang EH; Yamaguchi T; Tajima A; Nakajima T; Tomoyasu Y; Watanabe M; Yamaguchi M; Park SB; Maki K; Inoue I
    Arch Oral Biol; 2009 Jun; 54(6):556-62. PubMed ID: 19344888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency.
    Räz B; Janner M; Petkovic V; Lochmatter D; Eblé A; Dattani MT; Hindmarsh PC; Flück CE; Mullis PE
    J Clin Endocrinol Metab; 2008 Mar; 93(3):974-80. PubMed ID: 18029459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.
    Barbosa EJ; Palming J; Glad CA; Filipsson H; Koranyi J; Bengtsson BA; Carlsson LM; Boguszewski CL; Johannsson G
    J Clin Endocrinol Metab; 2009 Feb; 94(2):639-44. PubMed ID: 19050057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
    Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
    Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the functional exon 3 deleted growth hormone receptor polymorphism and symptomatic osteoarthritis in women.
    Claessen KM; Kloppenburg M; Kroon HM; Bijsterbosch J; Pereira AM; Romijn JA; van der Straaten T; Nelissen RG; Hofman A; Uitterlinden AG; Duijnisveld BJ; Lakenberg N; Beekman M; van Meurs JB; Slagboom PE; Biermasz NR; Meulenbelt I
    Ann Rheum Dis; 2014 Feb; 73(2):433-6. PubMed ID: 23740230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
    Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
    Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature.
    Hujeirat Y; Hess O; Shalev S; Tenenbaum-Rakover Y
    Horm Res; 2006; 65(4):210-6. PubMed ID: 16582564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.
    Montefusco L; Filopanti M; Ronchi CL; Olgiati L; La-Porta C; Losa M; Epaminonda P; Coletti F; Beck-Peccoz P; Spada A; Lania AG; Arosio M
    Clin Endocrinol (Oxf); 2010 May; 72(5):661-7. PubMed ID: 20447065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common exon 3 polymorphism of the GH receptor (GHR) gene and effect of GH therapy on growth in Korean children with idiopathic short stature (ISS).
    Ko JM; Park JY; Yoo HW
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):82-7. PubMed ID: 18793346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A polymorphism in the growth hormone receptor is associated with height in children with Prader-Willi syndrome.
    Park SW; Lee ST; Sohn YB; Kim SH; Cho SY; Ko AR; Ji ST; Kwon JY; Yeau S; Paik KH; Kim JW; Jin DK
    Am J Med Genet A; 2011 Dec; 155A(12):2970-3. PubMed ID: 22052808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
    Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions.
    Filopanti M; Giavoli C; Grottoli S; Bianchi A; De Marinis L; Ghigo E; Spada A
    J Endocrinol Invest; 2011 Dec; 34(11):861-8. PubMed ID: 22322534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly.
    Cinar N; Dagdelen S; Yorgun H; Canpolat U; Kabakçı G; Erbas T
    Pituitary; 2015 Feb; 18(1):116-25. PubMed ID: 24706164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
    Tauber M; Ester W; Auriol F; Molinas C; Fauvel J; Caliebe J; Nugent T; Fryklund L; Ranke MB; Savage MO; Clark AJ; Johnston LB; Hokken-Koelega AC;
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the human growth hormone receptor and IGF-I coding sequences in children with growth disorders.
    Obrepalska-Steplowska A; Kedzia A; Goździcka-Józefiak A; Jakubowicz M; Korman E
    J Pediatr Endocrinol Metab; 2003; 16(6):819-25. PubMed ID: 12948293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.